Heart Health
Cardiawave Launches Valvosoft Treatments Post-CE Mark Approval
The CE Mark clearance positions Valvosoft within Europe's growing cardiac therapeutics market as the company accelerate…
Heart Health 2 stories
Heart Health
Atavistik Bio Wins FDA Fast Track for ATV-1601 in Rare Vascular Disease
Fast Track status shortens FDA review timelines for serious conditions with unmet need — a designation increasingly rel…